Stock listing
Camp4 Therapeutics Corporation
Selected listing: CAMP · BOATS · USD · US
Camp4 Therapeutics Corporation (BOATS:CAMP), Health Technology. Latest release Sep 10, 2026: CAMP4 Therapeutics Receives Authorization in the United Kingdom…
- Ticker
- BOATS:CAMP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
About Camp4 Therapeutics Corporation
The company focuses on developing innovative therapeutic solutions. As a player in the biotechnology sector, Camp4 is dedicated to advancing treatments that address unmet medical needs.
Latest news from Camp4 Therapeutics Corporation
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
September 10, 2026
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
September 8, 2026
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 13, 2026
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
August 4, 2026
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
July 27, 2026
Events
Research Camp4 Therapeutics Corporation
Camp4 Therapeutics Corporation company profile
View the public company page for Camp4 Therapeutics Corporation on 6ix.
Camp4 Therapeutics Corporation news
Read company news and market updates connected to Camp4 Therapeutics Corporation.
Camp4 Therapeutics Corporation investor events
Find investor webinars, events, and replay context for Camp4 Therapeutics Corporation.